Stop Big Pharma’s $4 Billion Bailout

As the country is hoping for lower drug prices, more affordable care, and solutions to the opioid epidemic sweeping the nation, Big Pharma is making backroom deals with Congress to fund a $4 billion bailout.

Using the opioid package as its vehicle, Big Pharma is pushing to lower drug makers’ liability in the doughnut hole from 70% to 63% – which comes as the expense of the American taxpayers, and especially patients and seniors who rely on Medicare Part D.

According to Axios: “Congress voted earlier this year to shift billions of dollars in Medicare drug costs away from seniors and onto drug companies. Now, “PhRMA is begging” lawmakers to reverse that decision in unrelated opioids legislation…”

What’s more – this bill could wind up costing far more than the policies included that help address the opioid crisis. Only Big Pharma would use bipartisan opioid legislation as another opportunity to make money off the very crisis they themselves created.

If Big Pharma gets its way, this legislation will no longer focus on helping communities affected by the opioid epidemic, but will instead further enrich Big Pharma – on the backs of hardworking American taxpayers and vulnerable seniors.

It’s time to hold Big Pharma accountable – and put the American people first.

Learn More:

• The Associated Press: Groups say Medicare discounts threatened in opioids bill
• The Hill: Lawmakers consider easing costs on drug companies as part of opioids deal
• Axios: Drug industry lobbying for a big Medicare break in opioids bill